[1]
Inciardi, PhD, J.A., Surratt, PhD, H.L., Stivers, BA, Y. and Cicero, PhD, T.J. 2018. FDA approvals of generic drugs: Impact on the diversion of opioid analgesics with a potential for abuse. Journal of Opioid Management. 5, 2 (Jan. 2018), 81–87. DOI:https://doi.org/10.5055/jom.2009.0009.